Shared first and # shared last authors. The phylogenetic relationships of Zaire ebolavirus have been intensively analysed over the course of the 2013-2016 outbreak. However, there has been limited consideration of the functional impact of this variation. Here we describe an analysis of the available sequence data in the context of protein structure and phylogenetic history. Amino acid replacements are rare and predicted to have minor effects on protein stability. Synonymous mutations greatly outnumber nonsynonymous mutations, and most of the latter fall into unstructured intrinsically disordered regions, indicating that purifying selection is the dominant mode of selective pressure. However, one replacement, occurring early in the outbreak in Gueckedou in Guinea on 31 st March 2014 (alanine to valine at position 82 in the GP protein), is close to the site where the virus binds to the host receptor NPC1 and is located in the phylogenetic tree at the origin of the major B lineage of the outbreak. The ! 19! selected residue changes occurring in the VP24 and VP35 protein structure (panels B and D, respectively).
indicated that, despite nucleotide variation, EBOV-Makona is functionally very similar to the variants responsible for previous outbreaks since 1976 9 . Here we extend this analysis to data sets sampled across the outbreak. The unprecedented dimensions of the EBOV-Makona outbreak mean that it is important to monitor for potential signs of viral adaptation to humans.
The evolutionary rates of EBOV in the current West African outbreak have been the subject of discussion 1, 3, 4, 6 with differences between studies largely due to sampling effects 4 . To understand how EBOV is changing, it is important to distinguish between the underlying mutation rate of the virus (random errors generated during replication) and its substitution rate (mutations that persist after being subject to genetic drift and/or selection). The mutations contributing to the elevated evolutionary rate over shorter timescales 1 are due to a) incomplete purifying selection and b) neutral nonsynonymous changes that are probably transient and so do not contribute to the ! 3! substitution rate over longer timescales. With regard to the capacity of EBOV to become adapted to the human population (i.e., endemic) the rate of evolutionary change is less important than the nature of these changes.
EBOV sequence variation must therefore be considered in the context of protein structure and protein-protein interactions. Protein function is tightly linked to protein structure and both are intrinsically linked to protein stability 10, 11 with proteins remaining folded and functional only within a relatively narrow range of temperatures.
Non-intuitively, an attenuated EBOV could result in lower viral loads and consequently greater host survival, as long as transmissibility is maintained. For example, the DNA virus myxoma exhibits rapid decreases in virulence due to deleterious mutations that maintained relative transmissibility 12 . Interestingly, there is evidence that EBOV-Makona has lower virulence relative to the 1976 outbreak EBOV-Mayinga 13 ; EBOV-Makona viral load is directly linked to survival 14 and at the population level patient viral loads (and hence virulence) decreased significantly from July to November in 2014 15 . This change may have contributed to increased transmission over the course of the 2013-2016 outbreak. The decrease in virulence might be due to host factors such as genetic differences or alterations in the immune system, or, alternatively, it may result from genetic change in the virus. An attenuated EBOV could be one where amino acid replacements thermodynamically destabilize the protein structure, allowing, for example, high fever in the host to partially control it.
Alternatively changes in functional sites could alter the dynamics of infection, for example, as a consequence of more (or less) efficient receptor binding.
! 4!
To investigate possible EBOV adaptation to humans we have characterised the functional consequences of amino acid residue changes in a structural and evolutionary context across the 2013-2016 outbreak. We find, although relatively rare, both stabilising and destabilising amino acid residue replacements and a tendency for residue changes in the intrinsically disordered regions of EBOV's proteins. We also find a single variant proximal to the site where the virus binds the host receptor that occurred in Guinea early in the evolution of the outbreak. We discuss the implications of these findings.
Results
We analysed all complete genome sequence data from the EBOV-Makona outbreak, sampled between March 2014 to January 2015, which was available by April 2015 [1] [2] [3] [4] [5] [6] [7] .
A relatively large degree of sequence diversity is observed in this data set ( Fig. 1 ).
However, we find no evidence of positive selection within the EBOV-Makona outbreak, with neither Slr nor PAML identifying a signal at statistical significance.
Sequence variability is highest in intergenic regions as these regions presumably have lower evolutionary constraint than protein-coding regions. Within the proteincoding genes, disordered regions accommodate a disproportionate amount of EBOV's nonsynonymous variation ( Fig. 1 ). In these regions the general characteristic of the protein sequence is more important than residues at particular sites; a much wider range of sequences are therefore compatible, and purifying selection is relaxed resulting in higher evolutionary rates. This lowered constraint allows more replacements in these regions, a signal not to be confused with positive selection 5, 16 .
Importantly, lack of evidence for positive selection (average nonsynonymous to synonymous substitution ratios <1, Fig. 1 ), does not necessarily mean a lack of ! 5! functional change. For example, residue replacements in intrinsically disordered regions of EBOV proteins GP and NP ( Fig. 2 and 3 ) may affect both protein-protein interactions and the host immune response. The disordered mucin-like domain in GP constitutes approximately one third of the protein and so is a major constituent of the external surface of the virus, a primary target of immune surveillance. Disordered regions do not have a single unique structure, but nonetheless have been implicated in virulence 17 . In particular the conserved short linear motifs (SLiMs) 18 form molecular interactions 19, 20 . SLiMs are found within the disordered regions ( Fig. S1 ) and may permit EBOV to form novel host interactions via "sticky" non-specific interactions with host proteins 21 , and so have the potential to randomly explore novel host perturbations.
To analyse and compare variation in EBOV proteins, molecular phylogenetic trees were constructed and ancestral genetic sequence changes reconstructed. By modelling EBOV sequences in the context of their three-dimensional proteins we studied the nature of the amino acid residue replacements (non-synonymous substitutions) through time on the phylogenetic tree. Replacements tend to be sparsely dispersed across the variants sampled, explaining the lack of structure in the inferred amino acid trees for all proteins (Fig. 2-4 ), with only a minority of changes being present in transmitted viruses.
In the GP protein we find 6 variants (Fig 2A) in the structured region. Two of these (replacement of Ala with Val at residue 222, and replacement of Thr 230 with Ala highlighted in red and grey respectively in Fig. 2A and B ) are in the glycan cap. The replacement at position 222 is predicted to have a relatively strong stabilising effect ! 6! with a ΔΔG of -3.2 kcal/mol, whereas that at position 230 is mildly destabilising. The glycan cap, along with the mucin domain, is cleaved to activate the GP protein 22 . Fig. 2A ) appears to be the most significant replacement. This variant (KR817182 -patient EM_079410 4 ) was first detected in Gueckedou Guinea on 31 st March 2014, before the spread to Sierra Leone, and corresponds to a nucleotide substitution of C to T at site 6281 ( Fig. S2 ) and is in the last common ancestor leading to the major Lineage B of the outbreak 4 , consistent with a selective sweep ( Fig. 2A ). Previous analysis of amino acid replacements did highlight this change 9, 23 , and Ladner et al. 8 We also observe a small number of strains in which GP is predicted to have increased thermal stability (detailed Fig. 2A ). These strains are frequently characterised by the combination of stabilising changes that precede later destabilising changes. This pattern of replacements demonstrates how stabilising replacements are potentially important as they can permit the accommodation of otherwise deleterious destabilising replacements, as has been demonstrated in enabling drug or antibiotic resistance to evolve 10, 11, 27, 28 Indeed in the GP phylogeny there is a cluster of six variants (corresponding to 33 infections) characterised by a destabilising replacement (replacement of Thr with Ala at residue 230, highlighted in grey in Fig. 2A In VP30 and VP40 there is a clear predominant variant with no clusters of more than two variants identifiable ( Fig. 4F and G) . Interestingly in VP24 there is a destabilising replacement (Met with Ile at residue 136, highlighted in yellow Fig. 4A ), which reduces the overall ΔΔG to 0.8 kcal/mol that corresponds to a cluster of 20 infections.
Replacement of Ala with Val at residue 82 (highlighted in yellow in

! 9!
This slightly destabilising replacement is near to the protein surface ( Fig. 4B ). As such, these residues are likely to be functionally equivalent. In VP35 there are residue changes that cluster in the phylogenetic tree, indicating that they might be functionally important. These replacements correspond to both stabilising (Arg with Lys at residue 225 and Leu with Phe at residue 330, highlighted in yellow and grey respectively, Fig. 4C ) and destabilising (Pro with Ser at residue 273, highlighted in red Fig. 4C ) changes that correspond to 5, 25 and 11 infections, respectively. These replacements are dispersed in the protein structure, although all three are close to the protein's surface ( Fig. 4D ). Of note this stabilising change in VP35 (corresponding to 25 infections) is embedded in the same cluster of viruses in VP24 characterised by a destabilising replacement (corresponding to 20 infections). Finally, in the L protein there are some sub-clusters ( Fig. 4E) , however, no structures are available to look at their context of these residue changes.
Discussion
Throughout the EBOV-Makona epidemic there was extensive monitoring for altered viral properties that could explain EBOV's "success" in comparison to previous outbreaks. None was found. In particular there was much focus on shifts in mutation rates and positive selection as an indicator of important change in the virus population. This emphasis is potentially misleading, since adaptation can arise by chance in a population regardless of the rate of evolution. Additionally concern had been raised about EBOV becoming adapted to humans via unspecified gain-offunction mechanisms, failing to recognize that a directional evolution can be associated with rare mutations that can be hard to detect in the case of a selective protein in the unprimed state 22 with both the primed 24 and primed and bound states 25 (Fig. 2D) allow not only the identification of a conformational change in the GP protein, but also allow this change to be associated with binding to the host receptor rather than with cleavage of the cap domain. Several point mutations and naturallyoccurring replacements around the binding site have been shown to alter binding properties. These include variants in both the receptor and GP protein 26 , which can both increase or decrease binding affinity. For example mutation of Thr 83 to Met (i.e. the site neighbouring the replacement we observe Ala 82 to Val) reduces binding, whereas mutation of Ala 141 to Val increases it 26 . The replacement of Asp 502 to Phe in the host receptor NPC1 is observed in the African Straw-coloured fruit bat, and protects this species from EBOV. Inspection of the crystal structure of the complex suggests that this replacement removes a charge-charge interaction between Asp 502 in the receptor and Lys 155 in the GP protein, replacing it with the weaker van der Waals interaction. The GP Ala 82 to Val replacement occurred in the GUI-1 lineage found in Guinea. sampled in early 2014 31 . The earliest wave of Liberian cases also came from within this lineage 32 . This variant is one of only two amino acid replacements to have arisen in the latest epidemic and to have become fixed ( Fig. S2) 23 . It is located in the 3 10 helix that undergoes conformational change upon binding, and is predicted to stabilise the unbound state. If this prediction is correct, this change will result in a decreased affinity of the virus for the host receptor NPC1.
EBOV infection is usually sufficiently severe that patients are immobilized and can be readily identified. If a less virulent variant were to "seed" a cluster of infections with a higher reproductive number (R) due to it being less immobilising and/or identifiable in ! 12! an infected person the result would be a wider and more rapid spread through the human population. Indeed there is evidence that EBOV is both less virulent in comparison to a previous outbreak 13 and has decreased in virulence as the EBOV-Makona epidemic progressed 15 . There is also evidence for persistence infection of EBOV survivors for up to a year and a half, including transmission in this time 33 .
The risk of viral attenuation, and corresponding adaptation of EBOV to humans, necessitates both monitoring and more research. Results from our analysis are likely to be conservative because much of the available data was sampled from the sickest individuals. Typically, virus is characterised in patients with high levels of viral RNA as assessed with a real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)-based threshold cycle (CT) value 34 . For example, in one of our main data sets 4 infected patients were chosen with a CT value of 20 or below and for these patients the survival rate was 20%.
Interestingly, bats, the probable host reservoir of EBOV, have a peak body temperature of ~42˚C due to the metabolic requirements of flight 35 . In human infections, EBOV is thus replicating at lower temperatures than its usual bat host.
This new niche for EBOV has potentially important consequences for protein folding/stability, the tolerance for change and ultimately viral fitness in the new host species. If transmission to humans is relaxing structural/functional constraints on EBOV proteins, e.g., for thermal stability, less virulent variants could emerge associated with deleterious change. These variants could be at least partially controlled by fever, and so become less debilitating.
!
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In conclusion, our results demonstrate that EBOV was relatively stable in the human population. Coupled with the lack of evidence for change across previous outbreaks 36 this implies EBOV, unlike most viral cross-species transmissions, does not require significant adaptation 37 to replicate efficiently in humans. On this occasion, EBOV was prevented from establishing in the human population and becoming endemic, by drastic intervention strategies and changes in human behaviour that were feasible due to the relative ease of identifying infected individuals without any requirement for testing. It cannot be assumed that high virulence will always be the case for future EBOV outbreaks. Continued monitoring for outbreaks and rapid intervention is, thus, an imperative if we are to prevent EBOV becoming endemic in humans.
Online Methods
Viral genomes were obtained from blood taken from 179 patients in Guinea and sent to the European Mobile Laboratory (EMLab) for sequencing (see ref 4 for full details).
This data was combined with the available EBOV genome sequence data from the EBOV-Makona outbreak (476 genomes) 1-7 and sequences containing stop codons within genes or sequence ambiguities discarded. The remainder were aligned using MAFFT v.7.215 (http://mafft.cbrc.jp/alignment/software) and non-coding regions removed using MEGA v.6 (http://www.megasoftware.net). The alignment was then partitioned into individual alignments for each gene and duplicate sequences removed. All alignments are available from DOI: 10.17635/lancaster/researchdata/6. 
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Gene Red lines indicate the region is likely to bind to other proteins while blue lines indicates the region is not likely to bind. Straight lines link different red curves.
